Nova EYE Medical Ltd Total Assets
Nova EYE Medical Ltd total assets. Based on the latest financial reports, Nova EYE Medical Ltd (EYE) holds total assets worth AU$21.59 Million AUD (≈ $15.27 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Nova EYE Medical Ltd (EYE) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Nova EYE Medical Ltd (1989–2026)
Total assets of Nova EYE Medical Ltd from 1989 to 2026. This chart illustrates how Nova EYE Medical Ltd's total assets have evolved over time, based on quarterly financial data. See Nova EYE Medical Ltd (EYE) stock price for real-time trading data and today's change.
Nova EYE Medical Ltd - Asset Composition Analysis
Nova EYE Medical Ltd Total Assets Breakdown (June 2026)
Nova EYE Medical Ltd total assets breakdown as of June 2026. Nova EYE Medical Ltd's total assets of AU$21.59 Million consist of 44.6% current assets and 55.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 4.5% |
| Accounts Receivable | AU$5.11 Million | 23.7% |
| Inventory | AU$3.24 Million | 15.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$9.20 Million | 42.6% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1989–2026)
This chart illustrates how Nova EYE Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Nova EYE Medical Ltd to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nova EYE Medical Ltd's current assets represent 44.6% of total assets in 2026, an increase from 35.7% in 1989.
- Cash Position: Cash and equivalents constituted 4.5% of total assets in 2026, down from 5.1% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is intangible assets at 42.6% of total assets.
Nova EYE Medical Ltd Competitors by Total Assets
Key competitors of Nova EYE Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
Nova EYE Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.74 | 2.39 | 5.62 |
| Quick Ratio | 1.15 | 1.85 | 5.00 |
| Cash Ratio | 0.00 | 0.98 | 3.80 |
| Working Capital | AU$4.09 Million | AU$7.17 Million | AU$21.64 Million |
Nova EYE Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Nova EYE Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.79 |
| Latest Market Cap to Assets Ratio | 1.31 |
| Asset Growth Rate (YoY) | -18.5% |
| Total Assets | AU$21.59 Million |
| Market Capitalization | $28.22 Million USD |
Valuation Analysis
Above Book Valuation: The market values Nova EYE Medical Ltd's assets above their book value (1.31x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Nova EYE Medical Ltd's assets decreased by 18.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nova EYE Medical Ltd (1989–2026)
The table below shows the annual total assets of Nova EYE Medical Ltd from 1989 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-06-30 | AU$21.59 Million ≈ $15.27 Million |
-18.55% |
| 2025-06-30 | AU$26.50 Million ≈ $18.75 Million |
-11.30% |
| 2024-06-30 | AU$29.88 Million ≈ $21.14 Million |
-1.56% |
| 2023-06-30 | AU$30.36 Million ≈ $21.48 Million |
-17.11% |
| 2022-06-30 | AU$36.62 Million ≈ $25.91 Million |
-12.79% |
| 2021-06-30 | AU$41.99 Million ≈ $29.71 Million |
-64.03% |
| 2020-06-30 | AU$116.74 Million ≈ $82.60 Million |
+16.87% |
| 2019-06-30 | AU$99.89 Million ≈ $70.68 Million |
-3.45% |
| 2018-06-30 | AU$103.47 Million ≈ $73.21 Million |
+19.55% |
| 2017-06-30 | AU$86.54 Million ≈ $61.23 Million |
+20.21% |
| 2016-06-30 | AU$71.99 Million ≈ $50.94 Million |
+22.06% |
| 2015-06-30 | AU$58.98 Million ≈ $41.73 Million |
+8.76% |
| 2014-06-30 | AU$54.23 Million ≈ $38.37 Million |
+14.54% |
| 2013-06-30 | AU$47.35 Million ≈ $33.50 Million |
+5.37% |
| 2012-06-30 | AU$44.93 Million ≈ $31.79 Million |
-7.13% |
| 2011-06-30 | AU$48.38 Million ≈ $34.23 Million |
-6.20% |
| 2010-06-30 | AU$51.58 Million ≈ $36.49 Million |
+1.32% |
| 2009-06-30 | AU$50.91 Million ≈ $36.02 Million |
-29.24% |
| 2008-06-30 | AU$71.94 Million ≈ $50.90 Million |
+12.96% |
| 2007-06-30 | AU$63.69 Million ≈ $45.06 Million |
+37.03% |
| 2006-06-30 | AU$46.48 Million ≈ $32.88 Million |
+19.00% |
| 2005-06-30 | AU$39.05 Million ≈ $27.63 Million |
+1.93% |
| 2004-06-30 | AU$38.31 Million ≈ $27.11 Million |
+3.34% |
| 2003-06-30 | AU$37.08 Million ≈ $26.23 Million |
-4.37% |
| 2002-06-30 | AU$38.77 Million ≈ $27.43 Million |
+3283.99% |
| 2001-06-30 | AU$1.15 Million ≈ $810.63K |
+114.51% |
| 2000-06-30 | AU$534.07K ≈ $377.89K |
-5.82% |
| 1999-06-30 | AU$567.06K ≈ $401.23K |
-44.12% |
| 1998-06-30 | AU$1.01 Million ≈ $718.09K |
-41.42% |
| 1997-06-30 | AU$1.73 Million ≈ $1.23 Million |
-1.68% |
| 1996-06-30 | AU$1.76 Million ≈ $1.25 Million |
+43.73% |
| 1995-06-30 | AU$1.23 Million ≈ $867.47K |
+301.97% |
| 1994-06-30 | AU$305.00K ≈ $215.81K |
-44.04% |
| 1993-06-30 | AU$545.00K ≈ $385.62K |
-35.43% |
| 1992-06-30 | AU$844.00K ≈ $597.18K |
-29.55% |
| 1991-06-30 | AU$1.20 Million ≈ $847.66K |
-13.94% |
| 1990-06-30 | AU$1.39 Million ≈ $984.93K |
-64.11% |
| 1989-06-30 | AU$3.88 Million ≈ $2.74 Million |
-- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more